Recludix Pharma
Xia Tian has worked in the pharmaceutical and biotechnology industries since 2000. Xia began their career as a Graduate Student Researcher at UC Irvine in 2000, followed by a Research Associate position at Exelixis in 2001. From 2008 to 2009, they were a Postdoctoral Associate at UCLA, and then a Research Fellow at Boston University from 2009 to 2010. Xia then moved to X-Chem, Inc. where they held two roles, Senior Research Scientist and Research Scientist, from 2010 to 2018. In 2018, they became a Principle Scientist at Arrakis Therapeutics, and then Director of Discovery Chemistry at Nurix Therapeutics in 2020. Currently, Xia Tian is the Director of Medicinal Chemistry at Recludix Pharma.
Xia Tian attended the University of California, Berkeley from 1996 to 2010, where they earned a Bachelor of Science (BS) in Chemistry. Xia then attended UC Irvine from 2002 to 2007, where they earned a Doctor of Philosophy (PhD) in Chemistry.
This person is not in the org chart
This person is not in any offices
Recludix Pharma
Recludix is a leader in developing platform approaches to discover potent and selective inhibitors of challenging protein targets by integrating custom generated DNA-encoded libraries, massively parallel determination of structure activity relationships, and a proprietary screening tool to ensure selectivity.